Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node-negative breast cancer

International Journal of Cancer

Volumn 72, Issue 4, 1997, Pages 599-603

  Lizard Nacol, Sarab ^a   Riedinger, Jean Marc ^a   Lizard, Gérard ^b   Glasser, Anne Lise ^c   Coudray, Nolwenn ^d   Chaplain, Gilles ^e   Guerrin, Jaeques ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b HÔPITAL DU BOCAGE   (France)

^c INSERM   (France)

^d INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e Côte d' or Digestive Cancer Registry   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL TRANSFORMATION; CHROMOSOME 17P; GENE MUTATION; GENETIC STABILITY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENES, P53; HETEROZYGOTE; HUMANS; LYMPH NODES; MIDDLE AGED; ONCOGENES;

EID: 0030740543     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970807)72:4<599::AID-IJC8>3.0.CO;2-L     Document Type: Article

References (22)

1. BERNS, E.M, KLIJN, J.G., VAN PATTEN, W.L., STAVEREN, P.L., PORTENGEN, H. and FOEKENS, J.A., c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res., 52, 1107-1113 (1992).
2. CHAMPÈNE, H., BIÈCHE, I., LIZARD, S. and LIDEREAU, R., 11q13 amplification in local recurrence of human primary cancer. Genes Chromosomes Cancer, 12, 128-133 (1995).
3. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid-guanidinium-thiocyanate-phenol-chloroform extraction. Ann. Biochem., 162, 156-159 (1987).
4. COLES, C., CONDIE, A., CHETTY, U., STEEL, C.M., EVANS, H.J. and PROSSER, J., p53 mutations in breast cancer. Cancer Res., 52, 5291-5298 (1992).
5. COLES, C., THOMPSON, A.M., ELDER, P.A., COHEN, B.B., MACKENZIE, I.M., CRANSTON, G., CHETTY, U., MACKAY, J., MACDONALD, M., NAKAMURA, Y., HOYHEIM, B. and STEEL, C.M., Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336, 761-763 (1990).
6. DENG, G., CHEN, L.C., SCHOTT, D.R., THOR, A., BHARGAVA, V., LJUNG, B.M., CHEW, K. and SMITH, H.S., Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res., 54, 499-505 (1994).
7. DOBASHI, M.D., DAVIS, J.G., MIKAMI, Y., FREEMAN, J.K., HAMURO, J. and GREENE, M.P., Characterisation of a neu/c-erbB-2-protein-specific activating factor. Proc. nat. Acad. Sci. (Wash.), 88, 8582-8586 (1991).
8. ESCOT, C., THEILLET, C., LIDEREAU, R., SPYRATOS, F., CHAMPÈNE, M.H., GEST, J. and CALLAHAN, R., Genetic alteration of the c-myc proto-oncogene (MYC) in human primary breast carcinomas. Proc. nat. Acad. Sci. (Wash.), 83, 4834-4838 (1986).
9. EYFJÖRD, I.E., THORLACIUS, S., STEINARSDOTTIR, M., VALGARDSDOTTIR, R., ÖGMUNDSDOTTIR, H.M. and JONSSON, K., p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res., 55, 646-651 (1995).
10. FINLAY, C.A., HINDS, P.W. and LEVINE, A.J., The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57, 1083-1093 (1989).
11. FOEKENS, J.A., RIO, M.C., SEGUIN, P., VAN PUTTEN, W.L.J., FAUQUE, J., NAP, M., KLIJN, J.G.M. and CHAMBON, P., Prediction of relapse and survival in breast-cancer patients by pS2 protein status. Cancer Res., 50, 3832-3837 (1990).
12. HASEGAWA, H., UEDA, M., FURUKAWA, K., WATANABE, M., TERAMOTO, T., MUKAI, M. and KITAJIMA, M., p53 gene mutations in early colorectal carcinoma. De novo vs. adenoma-carcinoma sequence. Int. J. Cancer, 64, 47-51 (1995).
13. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancers. Science, 253, 49-53 (1991).
14. KUTE, T.E., SHAO, Z.M., SUGG, N.K., LONG, R.T., RUSSELL, G.B. and CASE, L.D., Cathepsin D as a prognostic indicator for node-negative breast-cancer patients using both immuno-assays and enzymatic assays. Cancer Res., 52, 5198-5203 (1992).
15. LIZARD-NACOL, S., LIDEREAU, R., CULLIN, F., ARNAL, M., HAHNEL, L., ROIGNOT, P., CUISENIER, J. and GUERRIN, J., Benign breast disease: absence of genetic alterations at several loci implicated in breast-cancer malignancy. Cancer Res., 55, 4416-4419 (1995).
16. MACKEY, J., THOMPSON, A.M. and COLES, C., Molecular lesions in breast cancer. Int. J. Cancer, Suppl. 5, 47-50 (1990).
17. MILLIKAN, R. and 12 OTHERS, p53 mutations in benign breast tissue. J. clin. Oncol., 13, 2293-2300 (1995).
18. POLLER, D.N., ROBERTS, E.C., BELL, J.A., ELSTON, C.W., BLAMEY, R.W. and ELLIS, I.O., p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum. Pathol., 24, 463-168 (1993).
19. PRESS, M.F., PIKE, M.C., CHAZIN, V.R., HUNG, G., UDOVE, J.A., MAEKOWICZ, M., DANYLUK, J., GODOLPHIN, W., SLIWKOWSKI, M., AKITA, R., PATERSON, M.C. and SLAMON, D.J., her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of over-expression with increased risk of recurrent disease. Cancer Res., 53, 4960-4970 (1993).
20. RADFORD, D.M., FAIR, K., THOMPSON, A.M., RITTER, J.H., HOLT, M., STEINBRUECK, T., WALLACE, M., WELLS, S.A. JR. and DONIS-KELLER, H.R., Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res., 53, 2947-2950 (1993).
21. SOUTHERN, E.M., Detection of a specific sequence among DNA fragments separated by gel electrophoresis. J. mol. Biol., 98, 503-517 (1975).
22. YOUNES, M., LEBOVITZ, R.M., BOMMER, K.E., CAGLE, P.T., MORTON, D., KHAN, S. and LAUCIRICA, R., p53 accumulation in benign breast-biopsy specimens. Hum. Pathol., 26, 155-158 (1995).